Craig Collard - Jun 10, 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Craig Collard
Stock symbol
OPNT
Transactions as of
Jun 10, 2022
Transactions value $
$63,266
Form type
4
Date filed
6/13/2022, 04:55 PM
Previous filing
May 17, 2022
Next filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $19.1K +1.66K +3.46% $11.50 49.8K Jun 10, 2022 Direct F1
transaction OPNT Common Stock Purchase $44.1K +4.04K +8.11% $10.94 53.8K Jun 13, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $11.48 to $11.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $10.82 to $10.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.